FDA Approved: AZILECT — Original Application (Teva Neuroscience, Inc.)

View source ↗

Summary

FDA approved AZILECT (rasagiline mesylate) as an original application from Teva Neuroscience for the treatment of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

ORIG AP for AZILECT (RASAGILINE MESYLATE)